MedPath

Efficacy of azelaic acid 20% versus anthralin 1% in scalp alopecia areata

Phase 3
Recruiting
Conditions
Alopecia areata.
Alopecia areata
Registration Number
IRCT20091012002581N8
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Having alopecia areata scalp
Not receiving treatment during the previous month
Consent for the study

Exclusion Criteria

Pregnant women
Receiving effective treatments for alopecia areata taking corticosteroids and immunosuppressants and immunomodulators during the past month
Alopecia areata in a location other than the scalp and Alopecia areata universalis

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient recovery rate. Timepoint: Every month after intervention for 6 months. Method of measurement: Clinical examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath